|The La antigen binds 5′ noncoding region of the hepatitis C virus RNA in the context of the initiator AUG codon and stimulates internal ribosome entry site-mediated translation|
N Ali, A Siddiqui
Proceedings of the National Academy of Sciences 94 (6), 2249-2254, 1997
|Interaction of polypyrimidine tract-binding protein with the 5'noncoding region of the hepatitis C virus RNA genome and its functional requirement in internal initiation of …|
N Ali, A Siddiqui
Journal of virology 69 (10), 6367-6375, 1995
|An RNA pseudoknot is an essential structural element of the internal ribosome entry site located within the hepatitis C virus 5'noncoding region.|
C Wang, SY Le, N Ali, A Siddiqui
Rna 1 (5), 526-537, 1995
|Human La antigen is required for the hepatitis C virus internal ribosome entry site-mediated translation|
N Ali, GJM Pruijn, DJ Kenan, JD Keene, A Siddiqui
Journal of Biological Chemistry 275 (36), 27531-27540, 2000
|Cell-free replication of the hepatitis C virus subgenomic replicon|
N Ali, KD Tardif, A Siddiqui
Journal of Virology 76 (23), 12001-12007, 2002
|Demonstration of functional requirement of polypyrimidine tract-binding protein by SELEX RNA during hepatitis C virus internal ribosome entry site-mediated translation initiation|
A Anwar, N Ali, R Tanveer, A Siddiqui
Journal of Biological Chemistry 275 (44), 34231-34235, 2000
|Role of La autoantigen and polypyrimidine tract-binding protein in HCV replication|
AM Domitrovich, KW Diebel, N Ali, S Sarker, A Siddiqui
Virology 335 (1), 72-86, 2005
|DCLK1 regulates pluripotency and angiogenic factors via microRNA-dependent mechanisms in pancreatic cancer|
SM Sureban, R May, D Qu, N Weygant, P Chandrakesan, N Ali, ...
PloS one 8 (9), 2013
|Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts|
N Ali, H Allam, R May, SM Sureban, MS Bronze, T Bader, S Umar, ...
Journal of virology 85 (23), 12292-12303, 2011
|XMD8-92 inhibits pancreatic tumor xenograft growth via a DCLK1-dependent mechanism|
SM Sureban, R May, N Weygant, D Qu, P Chandrakesan, ...
Cancer letters 351 (1), 151-161, 2014
|Small molecule kinase inhibitor LRRK2-IN-1 demonstrates potent activity against colorectal and pancreatic cancer through inhibition of doublecortin-like kinase 1|
N Weygant, D Qu, WL Berry, R May, P Chandrakesan, DB Owen, ...
Molecular cancer 13 (1), 103, 2014
|Endoscopic and histologic features of immune checkpoint inhibitor-related colitis|
Y Wang, H Abu-Sbeih, E Mao, N Ali, W Qiao, VA Trinh, C Zobniw, ...
Inflammatory bowel diseases 24 (8), 1695-1705, 2018
|Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson|
Y Wang, H Abu-Sbeih, E Mao, N Ali, FS Ali, W Qiao, P Lum, G Raju, ...
Journal for immunotherapy of cancer 6 (1), 37, 2018
|The hepatitis C virus-induced NLRP3 inflammasome activates the sterol regulatory element-binding protein (SREBP) and regulates lipid metabolism|
S McRae, J Iqbal, M Sarkar-Dutta, S Lane, A Nagaraj, N Ali, G Waris
Journal of Biological Chemistry 291 (7), 3254-3267, 2016
|Conducting scaffolds for liver tissue engineering|
A Tahmasbi Rad, N Ali, HSR Kotturi, M Yazdimamaghani, J Smay, ...
Journal of Biomedical Materials Research Part A 102 (11), 4169-4181, 2014
|DCLK1 facilitates intestinal tumor growth via enhancing pluripotency and epithelial mesenchymal transition|
P Chandrakesan, N Weygant, R May, D Qu, HR Chinthalapally, ...
Oncotarget 5 (19), 9269, 2014
|Initiation factor eIF2-independent mode of c-Src mRNA translation occurs via an internal ribosome entry site|
H Allam, N Ali
Journal of Biological Chemistry 285 (8), 5713-5725, 2010
|Brief report: Dclk1 deletion in tuft cells results in impaired epithelial repair after radiation injury|
R May, D Qu, N Weygant, P Chandrakesan, N Ali, SA Lightfoot, L Li, ...
Stem cells 32 (3), 822-827, 2014
|Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells|
D Qu, J Johnson, P Chandrakesan, N Weygant, R May, N Aiello, A Rhim, ...
PloS one 10 (2), 2015
|Plasma DCLK1 is a marker of hepatocellular carcinoma (HCC): Targeting DCLK1 prevents HCC tumor xenograft growth via a microRNA-dependent mechanism|
SM Sureban, MF Madhoun, R May, D Qu, N Ali, J Fazili, N Weygant, ...
Oncotarget 6 (35), 37200, 2015